How to buy Harpoon Therapeutics (HARP) stock

Harpoon Therapeutics, Inc is a biotechnology business based in the US. Harpoon Therapeutics shares (HARP) are listed on the NASDAQ and all prices are listed in US Dollars. Harpoon Therapeutics employs 84 staff and has a trailing 12-month revenue of around 0.00.

Harpoon Therapeutics stock price (NASDAQ: HARP)

Use our graph to track the performance of HARP stocks over time.

Harpoon Therapeutics shares at a glance

• Key figures

Information last updated 2021-07-23.

Latest market close	$20.62
52-week range	$10.55 - $25.24
50-day moving average	$14.38
200-day moving average	$18.90
Wall St. target price	$29.30
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-4.05

Buy Harpoon Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Harpoon Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Harpoon Therapeutics, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Harpoon Therapeutics price performance over time

Historical closes compared with the close of $20.62 from 2021-05-28

1 week (2021-07-16)	N/A
1 month (2021-06-25)	41.04%
3 months (2021-04-27)	-2.64%
6 months (2021-01-23)	N/A

1 year (2020-07-23)	N/A
2 years (2019-07-23)	N/A
3 years (2018-07-23)	N/A
5 years (2016-07-23)	N/A

Harpoon Therapeutics financials

Revenue TTM	$23.2 million
Gross profit TTM	$-35,121,000
Return on assets TTM	-14.75%
Return on equity TTM	-106.73%
Profit margin	0%
Book value	$3.16
Market capitalisation	$361.7 million

TTM: trailing 12 months

Shorting Harpoon Therapeutics shares

There are currently 2.0 million Harpoon Therapeutics shares held short by investors – that's known as Harpoon Therapeutics's "short interest". This figure is 69.1% up from 1.2 million last month.

There are a few different ways that this level of interest in shorting Harpoon Therapeutics shares can be evaluated.

Harpoon Therapeutics's "short interest ratio" (SIR)

Harpoon Therapeutics's "short interest ratio" (SIR) is the quantity of Harpoon Therapeutics shares currently shorted divided by the average quantity of Harpoon Therapeutics shares traded daily (recently around 572320.11661808). Harpoon Therapeutics's SIR currently stands at 3.43. In other words for every 100,000 Harpoon Therapeutics shares traded daily on the market, roughly 3430 shares are currently held short.

However Harpoon Therapeutics's short interest can also be evaluated against the total number of Harpoon Therapeutics shares, or, against the total number of tradable Harpoon Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Harpoon Therapeutics's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Harpoon Therapeutics shares in existence, roughly 60 shares are currently held short) or 0.1083% of the tradable shares (for every 100,000 tradable Harpoon Therapeutics shares, roughly 108 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Harpoon Therapeutics.

Find out more about how you can short Harpoon Therapeutics stock.

Harpoon Therapeutics share dividends

We're not expecting Harpoon Therapeutics to pay a dividend over the next 12 months.

Harpoon Therapeutics share price volatility

Over the last 12 months, Harpoon Therapeutics's shares have ranged in value from as little as $10.55 up to $25.235. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Harpoon Therapeutics's is 0.8095. This would suggest that Harpoon Therapeutics's shares are less volatile than average (for this exchange).

Harpoon Therapeutics overview

Harpoon Therapeutics, Inc. , a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company's lead tri-specific t-cell activating construct (TriTAC) product candidate is HPN424, which is in Phase I/IIa clinical trials for the treatment of metastatic castration-resistant prostate cancer. It is also developing HPN536, which is in Phase I/IIa clinical trials for the treatment of ovarian cancer and other mesothelin-expressing tumors; HPN217 that is in Phase I/II clinical trials for the treatment of multiple myeloma; and HPN328, a product candidate in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors. The company has a discovery collaboration and license agreement with AbbVie Biotechnology Ltd. to develop and commercialize products that incorporate our proprietary TriTAC platform technology together with soluble T cell receptors. Harpoon Therapeutics, Inc.

Frequently asked questions

What percentage of Harpoon Therapeutics is owned by insiders or institutions?
Currently 7.772% of Harpoon Therapeutics shares are held by insiders and 82.553% by institutions. How many people work for Harpoon Therapeutics?
Latest data suggests 84 work at Harpoon Therapeutics. When does the fiscal year end for Harpoon Therapeutics?
Harpoon Therapeutics's fiscal year ends in December. Where is Harpoon Therapeutics based?
Harpoon Therapeutics's address is: 131 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 What is Harpoon Therapeutics's ISIN number?
Harpoon Therapeutics's international securities identification number is: US41358P1066 What is Harpoon Therapeutics's CUSIP number?
Harpoon Therapeutics's Committee on Uniform Securities Identification Procedures number is: 41358P106